If you are planning to invest a lot of money in the stock market, look at the following businesses first. These elite companies have proven to be wealth creators, and their stocks are all smart buys today.
microsoft
If you're looking for a low-risk way to profit from the growth of artificial intelligence (AI), look no further. microsoft (MSFT -0.71%). Thanks to ChatGPT maker's collaboration with OpenAI, the tech giant is well-positioned to deliver his AI-powered benefits to shareholders.
Since making a multibillion-dollar investment in OpenAI in early 2023, Microsoft has worked hard to integrate the AI startup's cutting-edge technology into its popular products and services. By building AI into software like Outlook, Word, Excel, and Teams, Microsoft helps the hundreds of millions of people who use these tools be more productive and efficient.
For companies and individuals adopting AI, the benefits of cost savings and innovation are potentially significant. As a result, demand for cloud services that power AI is expected to skyrocket.Global cloud computing market expected to grow approximately 18% annually to $2.50 Trillion By 2032, according to Acumen Research and Consulting. Microsoft stands to benefit here as well. Microsoft is set to benefit significantly from the rapid growth of the cloud market over the next decade, with its Azure cloud platform established as a leader in this fast-growing industry.
Eli Lilly
For nearly 70% of American adults who are obese or overweight; Eli Lilly's (LLY -2.31%) A new anti-obesity drug could be life-changing. These weight-related conditions tend to increase your chances of developing dangerous diseases such as diabetes and heart disease. Eli Lilly wants to help people live longer, healthier lives by losing excess weight faster and easier.
Zepbound, the healthcare giant's once-weekly injection for chronic weight management in adults, works by activating hormone receptors that reduce appetite. The results can be surprising. Participants who received the highest dose of treatment lost an average of 48 pounds during the 72-week clinical study.
Even better, people who took Zepbound and followed a low-calorie diet and exercise plan found that their cholesterol and blood pressure profiles improved. Additionally, Zepbound's active ingredient, tirzepatide, has been shown to improve blood sugar control in adults with type 2 diabetes. These results suggest that Eli Lilly's weight loss drug may have positive effects on several important health markers.
The healthcare giant's revenue is expected to grow more than 50% annually over the next five years, according to Yahoo! finance. Invest now and receive a portion of Eli Lilly's future profits.
costco wholesale
If you want to add defensive stocks to strengthen your diversified portfolio, consider the following: costco wholesale (Fee -7.64%). Bargain-hunting shoppers appreciate the discount retailer's low prices, and investors praise the company's steadily growing sales and profits.
Costco offers one of the most engaging shopping experiences of any retailer. Carefully selected high-quality products and ultra-low prices appeal to increasingly cost-conscious consumers. An ever-changing selection of products for sale adds a treasure-hunt-like dynamic that further fascinates customers.
Costco's popular membership program is another reason people shop at the store. By paying membership fees, people can maximize their return on investment by shopping at Costco and taking advantage of its low prices to increase their savings.
Additionally, the company's membership fees make up a large portion of its profits. These benefits, combined with the retail giant's massive size, are what allow Costco to offer such affordable prices.
The number of shoppers frequenting its stores is expected to continue to grow in the coming years, making Costco stock a great buy today.
Joe Tenebruso has no position in any stocks mentioned. The Motley Fool has positions in and recommends Costco He Wholesale and Microsoft. The Motley Fool recommends the following options: His January 2026 $395 long call on Microsoft and his January 2026 $405 short call on Microsoft. The Motley Fool has a disclosure policy.
